A study by researchers at Seoul National University Bundang Hospital (SNUBH) showed that the use of digital healthcare among older adults is poor, with half of the participants unable to install related applications despite smartphone use.Digital healthcare technology, including a wide range of heal
In a notable legal development, Hugel has secured a favorable outcome in its legal battles against the Ministry of Food and Drug Safety (MFDS) regarding the indirect export of Botulax, its botulinum toxin (BTX) products, which led to the revocation of its sales license. The Seoul Administrative Cour
Samsung Biologics said it has obtained the "Leadership A-"grade, the second highest of the eight grades, from Carbon Disclosure Project (CDP), a global sustainability assessment organization, for its climate change response efforts in 2023.The company stressed that it is the first in the domestic bi
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,
Celltrion said it has completed its application for marketing authorization to the European Medicines Agency (EMA) for CT-P47, a biosimilar referencing Actemra.Roche's Actemra (ingredient: tocilizumab), known as RoActemra in Europe, is approved for a wide range of conditions, including rheumatoid ar
Severance Hospital has succeeded in conducting Korea's first irreversible electroporation surgery technique on a 76-year-old liver cancer patient. The patient has since been discharged and is now resuming normal daily activities.IRE involves creating small gaps of about 2mm in the cancerous tissue b
OCI Holdings Chairman Lee Woo-hyun has reaffirmed the company's strategy to play a minimal role in the management of Hanmi Group following the upcoming integration with Hanmi Science.During an investor conference call on Wednesday, Chairman Lee stated that OCI Holdings intends to support Hanmi Group
Yuhan Corp. said it posted highest-ever annual sales in 2023 thanks to technology export revenue.The company reported consolidated sales and operating profit of 1.8 trillion won ($1.3 billion) and 56.7 billion won in 2023, up 4.7 percent and 57.6 percent year-on-year. Net profit also jumped 57.4 per
The Seoul High Court on Wednesday upheld the lower court's decision, rejecting Kolon Life Science's appeal to suspend the Ministry of Food and Drug Safety's order cancelling the approval for Invossa-K, a gene therapy for osteoarthritis.This decision marks the second defeat for Kolon Life Science in
Researchers at Seoul National University Bundang Hospital (SNUBH) have successfully developed and demonstrated a groundbreaking technology that expedites skin wound healing devoid of antibiotics, leveraging metal-organic frameworks (MOFs).Antibiotics have undeniably been instrumental in prolonging h
Bayer Korea said it has entered into a strategic partnership with Chong Kun Dang to co-market Kerendia (ingredienet: finerenone), Bayer's novel treatment for chronic kidney disease (CKD) in patients with type 2 diabetes.Kerendia received approval from the Ministry of Food and Drug Safety in May 2022
Samsung Biologics has announced a collaborative venture into the development of antibody-drug conjugate (ADC) therapies by signing a new contract development organization (CDO) agreement with LegoChem Biosciences, a Korean ADC developer.Under the accord, Samsung Biologics will participate in the ess
The Ministry of Health and Welfare's announcement on Tuesday to increase medical school admissions by 2,000 students from the 2025 academic year has sparked a major backlash from doctors.This marks the most significant expansion in medical education capacity in 27 years, elevating the current quota
Huons said it has signed a technology transfer agreement with EFIL BioScience for a functional material derived from the root vegetable parsnip, which is known for its potential benefits in supporting respiratory wellness.EFIL BioScience, established in 2021, is a Korean biotech startup focusing on
Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have made a discovery in the field of genetic regulation, highlighting the critical role of Alu elements in diseases such as tumor formation and neurodegenerative disorders.Alu elements, which make up about 10 percent of
Celltrion said that Rani Therapeutics has reported positive topline results from its phase 1 clinical trial of RT-111, an oral form of ustekinumab.The trial, conducted in Australia, involved 55 healthy adults and aimed to evaluate the pharmacokinetics (PK) and safety of RT-111, showcasing an impress
Chong Kun Dang said its consolidated operating profit surged by 124.4 percent on-year to 246.6 billion won ($184.7 million) in 2023, marking a record achievement thanks to its recent licensing deal with Novartis.The company's annual revenue increased by 12.2 percent to 1.6 trillion won last year, se
Daewoong Pharmaceutical said that the company achieved its highest-ever annual performance in 2023 across three key metrics -- sales, operating profit, and operating profit margin.On a standalone basis, the company reported sales of 1.2 trillion won ($900 million), an operating profit of 133.4 billi
Neurophet and ReadyCure said they have signed a business agreement to exchange business and conduct projects related to developing an Alzheimer's disease treatment.Under the accord, Neurophet will cooperate on developing ReadyCure's upcoming dementia treatment medical device, Helaxon.Utilizing its a